Further re Acquisition

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF Article 7 of EU Regulation 596/2014.

29 September 2016

Constellation Healthcare Technologies, Inc.

("Constellation Healthcare Technologies", "CHT", "Company" or the "Group")

Further re Acquisition of VEGA Medical Professionals LLC

Further to the announcement released on 23 September 2016, Constellation Healthcare Technologies, Inc., the US based Healthcare Services Company, announces that the shares potentially due to the vendors of Vega Medical Professionals LLC ("Vega") under the terms of the three year earn out have been allotted and will be held in an escrow account until such time as certain revenue and EBITDA targets have been met by VEGA. The maximum number of shares that could be issued under the terms of the earn out is 989,011 based on an issue price of £1.40 ("Deferred Consideration Shares").

Application has been made for the Deferred Consideration Shares to be admitted to trading on AIM and admission is expected to occur on 30 September 2016 ("Admission"). Following Admission, the total number of issued common shares in the Company will be 91,357,782. This figure has not changed from the announcement dated 23 September 2016 as the Deferred Consideration Shares were included in the calculation of this figure at that time. The Company does not hold any common shares in treasury and therefore this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.

Enquiries: